Loading...
You are viewing a DELETED record.
This record information is displayed for reference purpose only and should be not used.
This document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Living Modified Organism
(LMO)
The image below identifies the LMO through its unique identifier, trade name and a link to this page of the BCH. Click on it to download a larger image on your computer. For help on how to use it go to the LMO quick-links page.
Potato resistant to aminoglycoside antibiotics
EN
potato (Solanum tuberosum, variety Albatros) 35S-nptII
No
-
Organization:University of Rostock ()Academic or research institute, Agrobiotechnology - Faculty of Agricultural and Environmental SciencesFaculty of Agricultural and Environmental Sciences Justus-von-Liebig-Weg 6Rostock,
18059, GermanyPhone: +49 381 498 3001,Fax:Email: dekan.auf@uni-rostock.de,
This transgenic potato, variety Albatros, is resistent towards aminoglycoside antibiotics such as kanamycin, neomycin and geneticin. Such potatos are meant to be cultivated as control plants in field trials with differently genetically modified potato plants.
EN
The term “Recipient organism” refers to an organism (either already modified or non-modified) that was subjected to genetic modification, whereas “Parental organisms” refers to those that were involved in cross breeding or cell fusion.
-
BCH-ORGA-SCBD-12106-6 Organism Solanum tuberosum (Potato, SOLTU)Crops
EN
plant transformation vector 35S, derivate of pLH9000
EN
- Agrobacterium-mediated DNA transfer
Some of these genetic elements may be present as fragments or truncated forms. Please see notes below, where applicable.
-
BCH-GENE-SCBD-100287-7 CaMV 35S promoter | Cauliflower mosaic virus (CaMV)Promoter
-
BCH-GENE-SCBD-15001-5 Neomycin Phosphotransferase II | Escherichia coli (ECOLX)Protein coding sequence | Resistance to antibiotics (Kanamycin)
-
BCH-GENE-SCBD-100290-6 CaMV 35S terminator | Cauliflower mosaic virus (CaMV)Terminator
The LMO 35S-nptII expresses the nptII gene which confers resistance towards aminoglycoside antibiotics. The nptII gene is put under the control of the CaMV 35S promoter and -terminator.
EN
EN
- Research
PCR-based methods, to be developed on the information about the transformation vector
EN
EN
| Record type | Field | Record(s) | |||||
|---|---|---|---|---|---|---|---|
|
|||||||
|
|||||||
